Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment

By Schifitto Giovanni   Zhong Jianhui   Gill David   Peterson Derick   Gaugh Michelle   Zhu Tong   Tivarus Madalina   Cruttenden Kim   Maggirwar Sanjay   Gendelman Howard   Dewhurst Stephen   Gelbard Harris  

Journal of NeuroVirology, Vol. 15, Iss. 2, 2009-04 ,pp. : 176-186

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of d-Ala 1 -peptide T-amide for HIV-1-associated cognitive-motor impairment

By Goodkin Karl   Vitiello Benedetto   Lyman William   Asthana Deshratn   Atkinson J   Heseltine Peter   Molina Rebeca   Zheng Wenli   Khamis Imad   Wilkie Frances   Shapshak Paul  

Journal of NeuroVirology, Vol. 12, Iss. 3, 2006-07 ,pp. : 178-189

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Brain CD8+ and cytotoxic T lymphocytes are associated with, and may be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome

By Petito Carol   Torres-Muñoz Jorge   Zielger Fabiana   McCarthy Micheline  

Journal of NeuroVirology, Vol. 12, Iss. 4, 2006-08 ,pp. : 272-283

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease

By Liner Kevin   Hall Colin   Robertson Kevin  

Journal of NeuroVirology, Vol. 13, Iss. 4, 2007-07 ,pp. : 291-304

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy–treated subjects with human immunodeficiency virus type 1 infection

By Sun Bing   Abadjian Linda   Rempel Hans   Calosing Cyrus   Rothlind Johannes   Pulliam Lynn  

Journal of NeuroVirology, Vol. 16, Iss. 2, 2010-04 ,pp. : 115-124

Ashgate Publishing Ltd

Access to resources Recommend Favorite